Astronauts Neil Armstrong, Buzz Aldrin, and Michael Collins made history with the Apollo 11 mission, with Armstrong and Aldrin becoming the first men to set foot on the surface of the Moon. In a 2019 interview, Collins revealed how a bet he made with Armstrong was settled by Aldrin on the way down.
Collins recalled his memories with his two colleagues during the mission back in 2019, saying that Armstrong and Aldrin were wonderful colleagues to work with. He shared that shortly after their success on carrying out the experiments on the Moon, they were due to return to Earth, and he made a bet with Armstrong that they would not flip over when they returned but lost due to a mistake made by their other colleague.
“I had bet a case of beer with Neil that we would not flip over during return. We hit the ocean so fast that Buzz, who was all prepared, his hand was jerked off, and he missed the circuit breakers. I turned the switches and they didn’t work, because he hadn’t pushed in the breakers. So we flipped over into stable two and I owed Neil a case of beer,” shared Collins.
During the Apollo 11 mission, Armstrong and Aldrin carried out their experiments on the surface of the Moon while Collins was piloting the Columbia Command Module for 21 hours, waiting for their return. Even if only his two colleagues were able to set foot on the lunar surface, Collins shared that he did not feel envious of them at all. “I like being in the command module by myself, I had my own little way of doing things. I had hot coffee, I took the center seat, and it was almost like being in a little church. As far as feeling left out or anything, not at all, I felt very much an equal partner with them,” said Collins.
However, the legendary astronaut went on to reveal a slightly grim reality that they were facing while in space, as there was a possibility that Armstrong and Aldrin may not have made it back. Collins explained that the two astronauts only had one motor and that one motor had to work perfectly; otherwise, they would be stuck on the Moon, and he would be the only one who made it back to Earth.


FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Tabletop particle accelerator could transform medicine and materials science
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy 



